CONMED CORPORATION Net Income (Loss) Available to Common Stockholders, Diluted
CONMED CORPORATION (CNMD) reported Net Income (Loss) Available to Common Stockholders, Diluted of $15.84 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-10-26
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was $15.84M, a 65.68% decline year-over-year.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2023-06-30 was $13.73M.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2023-03-31 was $1.82M, a 89.10% decline year-over-year.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was $26.58M, a 8.75% increase year-over-year.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2022 was -$80.58M, a 228.84% decline from fiscal 2021.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2021 was $62.54M, a 557.16% increase from fiscal 2020.
- CONMED CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2020 was $9.52M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | $15.84M 10-Q · filed 2023-10-26 | $29.57M derived: sum of 2 quarters · filed 2023-10-26 | $31.39M 10-Q · filed 2023-10-26 | $57.97M derived: sum of 4 quarters · filed 2023-10-26 |
| 2023-06-30 | $13.73M 10-Q · filed 2023-07-27 | $15.55M 10-Q · filed 2023-07-27 | $42.13M derived: sum of 3 quarters · filed 2023-07-27 | $88.28M derived: sum of 4 quarters · filed 2023-10-26 |
| 2023-03-31 | $1.82M 10-Q · filed 2023-04-27 | $28.40M derived: sum of 2 quarters · filed 2023-04-27 | $74.55M derived: sum of 3 quarters · filed 2023-10-26 | -$93.74M derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-12-31 | $26.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $72.73M derived: sum of 2 quarters · filed 2023-10-26 | -$95.56M derived: sum of 3 quarters · filed 2023-10-26 | -$80.58M 10-K · filed 2023-02-21 |
| 2022-09-30 | $46.15M 10-Q · filed 2023-10-26 | -$122.14M derived: sum of 2 quarters · filed 2023-10-26 | -$107.17M 10-Q · filed 2023-10-26 | -$81.01M derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-06-30 | -$168.29M 10-Q · filed 2023-07-27 | -$153.32M 10-Q · filed 2023-07-27 | -$127.16M derived: sum of 3 quarters · filed 2023-07-27 | -$112.21M derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | $16.69M 10-Q · filed 2023-04-27 | $41.13M derived: sum of 2 quarters · filed 2023-04-27 | $56.08M derived: sum of 3 quarters · filed 2023-04-27 | $69.37M derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $39.39M derived: sum of 2 quarters · filed 2023-02-21 | $52.68M derived: sum of 3 quarters · filed 2023-02-21 | $62.54M 10-K · filed 2023-02-21 |
| 2021-09-30 | $14.95M 10-Q · filed 2022-10-27 | $28.24M derived: sum of 2 quarters · filed 2022-10-27 | $38.10M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $13.29M 10-Q · filed 2022-07-28 | $23.15M 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | $9.86M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $9.52M 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |